CCMI
IBB icon

Creative Capital Management Investments’s iShares Biotechnology ETF IBB Stock Holding History

Creative Capital Management Investments’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.9K Hold
68
– – ﹤0.01% 261
2026
Q1 		$11.5K Hold
68
– – ﹤0.01% 205
2025
Q4 		$11.5K Hold
68
– – ﹤0.01% 205
2025
Q3 		$9.82K Hold
68
– – ﹤0.01% 199
2025
Q2 		$8.6K Buy
+68
New +$8.35K ﹤0.01% 221
2025
Q1 		– Sell
-103
Closed -$13.6K – 257
2024
Q4 		$13.6K Buy
+103
New +$14.5K 0.01% 176

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Creative Capital Management Investments's IBB Position: Q2 2026 in Review

Creative Capital Management Investments held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 68 shares worth $12.9K. The position accounts for ﹤0.01% of the portfolio, ranked #261.

Creative Capital Management Investments first reported a position in IBB in Q4 2024 and has held it in 6 quarters since. The position peaked at $13.6K in Q4 2024. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Creative Capital Management Investments held 68 shares of iShares Biotechnology ETF worth $12.9K as of Q2 2026.
  • Creative Capital Management Investments left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #261 holding.
  • Creative Capital Management Investments first reported a position in iShares Biotechnology ETF in Q4 2024 and has held it in 6 quarters since.
  • Creative Capital Management Investments's iShares Biotechnology ETF position peaked at $13.6K in Q4 2024.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.